After combination treatment, the tumor site cellular infiltrates were accompanied by the enhanced elaboration of IL-12 and IFN-γ, but reduced release of the immunosuppressive mediators IL-10 and TGF-β1. The gene discussed is IL10; the disease is neoplasm.